Decreased mesencephalic locomotor region activation explains loss of presynaptic inhibition during step initiation in people with Parkinson´s disease with freezing of gait
Objective: To investigate if decreased mesencephalic locomotor activation (MRL) activation during step initiation in an-event related fMRI protocol would explain the loss of presynaptic inhibition…Impaired inhibitory control of saccadic eye movements in cervical dystonia: an eye tracking study
Objective: The aim of the present study was to assess the oculomotor performance of CD patients using eye tracking saccade paradigms. Background: The pathophysiology of…Loss of cortical inhibition in Parkinson’s disease
Objective: To evaluate motor cortex inhibition at different stages of Parkinson’s disease (PD). Background: In PD, striatal dopamine depletion produces profound alterations in the neural…Sensorimotor inhibition relates to gait dysfunction in people with Parkinson’s disease
Objective: To determine how sensorimotor inhibition relates to objective measures of gait OFF and ON levodopa and how having Parkinson’s disease (PD) affects this relationship.…Ipsilesional arm levitation after left hemispheric stroke: a case series
Objective: We present three patients with left hemispheric stroke and spontaneous ipsilesional arm levitation (IAL), a phenomenon not hitherto described. Background: Spontaneous arm levitation (AL) is…Cognitive Inhibitory Control and Response to Dopaminergic Medication in Parkinson’s Disease
Objective: To investigate whether response to dopaminergic medication (DM) correlates to inhibitory cognitive control (IC) in patients with Parkinson's disease (PD). Background: In the MDS…Opposite effects of dopamine on specific NoGo perfomance in young and late onset Parkinson’s disease and the relationship to nigrostriatal degeneration
Objective: To investigate inhibitory control under dopamine (DA) in Parkinson’s disease (PD). Background: The pattern of degeneration in PD as well as side effects of…Global inhibitory control in PD is impaired ON dopaminergic medication but not ON STN-DBS
Objective: The aim of our study is to obtain a better understanding of how DA and STN-DBS modulate basal ganglia (BG) pathway functions. Background: Patients…Dopamine agonist therapy mediates relationship between psychomotor inhibition and behavioral impulsivity in Parkinson’s disease.
Objective: Evaluate relationship between psychomotor inhibition and behavioral impulsivity in Parkinson’s disease (PD). Background: Impulse control disorders can be challenging iatrogenic effects of dopamine agonist…Functional deficits during response inhibition improve after dopaminergic medication for Parkinson
Objective: To study the neural correlates of impulse control in Parkinson's disease (PD) patients before and after the start of dopamine replacement therapy (follow up…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.